Oxygen therapy is one of the most established wound care treatments in medicine, with over 50 years of clinical evidence supporting its use for chronic and non-healing wounds. But “oxygen therapy for wounds” is not one therapy. It is a category that includes Hyperbaric Oxygen Therapy (HBOT) in hospital-grade chambers, topical oxygen devices applied directly to the wound bed, and normobaric oxygen delivery systems. Each has different evidence levels, insurance coverage rules, and clinical applications. Choosing the right approach depends on the wound type, severity, patient health, and whether insurance will pay for it.
This guide covers which oxygen therapy works best for which wounds, how clinical decisions are made, insurance coverage requirements, what happens at a wound care center, and home options for patients managing wounds between clinic visits.
Key Takeaways
- HBOT is FDA-cleared and insurance-covered for specific wound types, including diabetic foot ulcers, compromised skin grafts, and radiation tissue injury1
- Medicare covers HBOT for wounds only after 30 days of standard wound care has failed to show measurable improvement2
- Topical oxygen therapy (portable devices applied directly to the wound) is gaining evidence as a lower-cost alternative for certain wound types3
- Wound care centers with HBOT capabilities typically employ a multidisciplinary team (vascular surgeon, wound care nurse, hyperbaric technician)1
- Documentation of wound measurements, failed conventional treatments, and transcutaneous oxygen measurements (TCOM) is essential for insurance approval
- For more on how oxygen therapy promotes wound healing, see our guide on oxygen therapy for wounds. For topical approaches specifically, see topical oxygen therapy
Which Oxygen Therapy for Which Wound?
The clinical decision tree for oxygen therapy in wound care depends on wound type, severity, patient factors, and evidence support.
| Wound Type | First-Line Oxygen Therapy | Evidence Level | Insurance Coverage |
|---|---|---|---|
| Diabetic foot ulcer (Wagner grade 3+) | HBOT (hard chamber, 2.0-2.4 ATA) | Strong (multiple RCTs)4 | Medicare/most insurers after 30-day standard care |
| Compromised skin graft or flap | HBOT | Strong1 | Yes (FDA-cleared indication) |
| Radiation tissue injury (osteoradionecrosis) | HBOT | Strong5 | Yes (FDA-cleared indication) |
| Chronic venous leg ulcer | Topical oxygen therapy | Moderate (growing RCT data)3 | Variable; some Medicare coverage |
| Pressure ulcer (stage 3-4) | HBOT or topical oxygen | Moderate | Case-by-case; HBOT may be covered |
| Arterial insufficiency ulcer | HBOT (after vascular assessment) | Moderate | Often covered if vascular repair is not possible |
| Surgical wound (non-healing) | HBOT or topical oxygen | Moderate | Case-by-case |
| Minor wound (abrasion, small cut) | Standard wound care; oxygen therapy not indicated | N/A | N/A |
HBOT for Wound Care: How It Works
Hyperbaric Oxygen Therapy (HBOT) delivers 100% medical-grade oxygen at pressures above normal atmospheric pressure, typically 2.0 to 2.4 ATA (atmospheres absolute). At these pressures, blood plasma carries 10 to 15 times more dissolved oxygen than normal, flooding hypoxic wound tissue with the oxygen it needs to heal.
HBOT promotes wound healing through several mechanisms:1
- Angiogenesis: Stimulates the growth of new blood vessels into the wound bed, improving long-term oxygen and nutrient delivery
- Fibroblast activation: Oxygen-dependent collagen synthesis increases, supporting tissue rebuilding
- Bacterial killing: High oxygen levels are directly toxic to anaerobic bacteria and enhance neutrophil killing capacity
- Reduced edema: Hyperbaric oxygen causes vasoconstriction that reduces swelling without reducing oxygen delivery (the increased plasma oxygen compensates)
- Stem cell mobilization: HBOT stimulates the release of stem cells from bone marrow, contributing to tissue repair6
“Wound healing is fundamentally an oxygen-dependent process. Collagen synthesis, bacterial killing, angiogenesis, and epithelialization all require adequate tissue oxygen levels to proceed.”
Undersea and Hyperbaric Medical Society
Insurance Coverage and Documentation Requirements
HBOT for wound care is one of the few scenarios where insurance, including Medicare, reliably covers the therapy. But coverage requires specific criteria and documentation.
Medicare Coverage Criteria
Medicare covers HBOT for wounds under specific conditions:2
- The wound must fall into an approved diagnostic category (diabetic wounds of the lower extremity, chronic refractory osteomyelitis, osteoradionecrosis, soft tissue radionecrosis, compromised grafts/flaps)
- Standard wound care must have been attempted for at least 30 days without measurable improvement
- Transcutaneous oxygen measurement (TCOM) must demonstrate tissue hypoxia at the wound site (in-chamber values must show improvement, confirming the patient can benefit from HBOT)
- Continued HBOT coverage requires documented wound improvement. Medicare re-evaluates every 30 days
Documentation Checklist
Wound care centers that successfully obtain insurance approval maintain meticulous records. The documentation requirements include:
- Wound measurements: Length, width, and depth at every visit, with photographs
- TCOM values: Baseline (room air), in-chamber, and serial measurements showing response
- Failed conventional treatments: Documentation of wound care modalities attempted (debridement, compression, offloading, negative pressure wound therapy, advanced dressings)
- Vascular assessment: Ankle-brachial index (ABI), toe pressures, or duplex ultrasound to confirm adequate macrovascular supply
- Medical necessity letter: Physician statement explaining why HBOT is needed and what standard treatments have failed
- Progress notes: Regular documentation of wound response to HBOT
Topical Oxygen Therapy
Topical oxygen therapy (TOT) delivers oxygen directly to the wound surface through a sealed chamber or diffusion-based dressing applied over the wound. Unlike HBOT, which requires a full-body chamber and specialized facility, topical oxygen devices are portable and can be used at home or in outpatient settings.3
How it differs from HBOT:
- Oxygen is delivered locally, not systemically
- No pressurized chamber required
- Lower cost per treatment
- Can be applied continuously or for extended periods
- Does not provide systemic benefits (angiogenesis, stem cell mobilization, immune modulation)
Current evidence: A 2023 systematic review found that topical oxygen therapy significantly improved wound healing rates in diabetic foot ulcers compared to standard care alone, though the effect was smaller than that seen with HBOT.3 Topical oxygen is increasingly used for chronic venous leg ulcers and post-surgical wounds where systemic HBOT may not be needed or accessible.
Cost advantage: Topical oxygen devices range from $100 to $500 per unit, with disposable wound chambers costing $20 to $50 each. This compares favorably to HBOT sessions at $150 to $300 each in a wound care center.
What Happens at a Wound Care Center
Specialized wound care centers combine HBOT with comprehensive wound management. A typical treatment pathway includes:
- Initial assessment: Wound evaluation, vascular assessment (ABI, TCOM), medical history, nutritional status, glycemic control (for diabetic wounds)
- Standard wound care initiation: Debridement, appropriate dressings, offloading devices, compression therapy (for venous wounds), infection management
- HBOT evaluation (after 30 days if wounds are not progressing): TCOM testing to confirm tissue hypoxia and HBOT responsiveness
- HBOT protocol: Typically 20 to 40 sessions at 2.0 to 2.4 ATA, 90 minutes per session, 5 days per week
- Ongoing monitoring: Weekly wound measurements, monthly insurance re-authorization, TCOM re-testing as needed
Costs
| Therapy | Per Session/Unit Cost | Typical Total Cost | Insurance |
|---|---|---|---|
| HBOT (wound care center) | $150-$300/session | $3,000-$12,000 (20-40 sessions) | Covered for approved indications |
| Topical oxygen device | $100-$500 (device) + $20-$50 (chambers) | $300-$1,500 total | Variable; some Medicare coverage |
| Continuous oxygen diffusion dressing | $25-$75 per dressing | $200-$600/month | May be covered as wound care supply |
For insured patients with qualifying wound types, HBOT at a wound care center often has the lowest out-of-pocket cost because the bulk of the expense is covered by insurance. Patients pay copays and deductible amounts rather than the full session cost.
Home Oxygen Options for Wound Management
Between clinic visits, some patients use home-based oxygen therapies to support wound healing:
- Topical oxygen devices: Portable units that deliver oxygen directly to the wound through a sealed chamber. Can be used daily at home
- Oxygen-infused wound dressings: Dressings that generate or deliver oxygen to the wound bed over extended periods
- Ozonated oil: Some integrative practitioners recommend ozonated olive or sunflower oil applied to wound edges (distinct from medical oxygen therapy, limited evidence for wound healing)
Home oxygen therapy does not replace medical wound care or HBOT. It serves as a supplement between clinic-based treatments, potentially maintaining the oxygen-enriched environment that promotes healing.
The Bottom Line
Oxygen therapy for wound care is a well-established medical treatment with decades of clinical evidence and insurance coverage for specific indications. HBOT remains the most evidence-supported option for chronic, non-healing wounds, particularly diabetic foot ulcers, radiation tissue injury, and compromised grafts. Topical oxygen therapy is growing as a more accessible and lower-cost option for certain wound types.
For patients with chronic wounds, the most important step is evaluation at a specialized wound care center where TCOM testing can determine whether oxygen therapy is likely to help. Documentation of failed standard wound care is essential for insurance coverage. The combination of standard wound care plus appropriate oxygen therapy offers the best chance of healing for wounds that have not responded to conventional treatment alone.
References
- Undersea and Hyperbaric Medical Society. (2014). Hyperbaric Oxygen Therapy Indications, 13th Edition.
- Centers for Medicare & Medicaid Services. (2017). National Coverage Determination for Hyperbaric Oxygen Therapy (20.29). CMS Coverage Database
- Frykberg, R.G., et al. (2023). Systematic review of topical oxygen therapy for diabetic foot ulcers. Wound Repair and Regeneration, 31(3), 323-335. doi:10.1111/wrr.13076
- Löndahl, M., et al. (2010). Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care, 33(5), 998-1003. doi:10.2337/dc09-1754
- Marx, R.E. (1983). A new concept in the treatment of osteoradionecrosis. Journal of Oral and Maxillofacial Surgery, 41(6), 351-357. doi:10.1016/0278-2391(83)90294-X
- Thom, S.R., et al. (2006). Stem cell mobilization by hyperbaric oxygen. American Journal of Physiology: Heart and Circulatory Physiology, 290(4), H1378-H1386. doi:10.1152/ajpheart.00888.2005
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
